J
Jun Yi
Researcher at Fourth Military Medical University
Publications - 18
Citations - 311
Jun Yi is an academic researcher from Fourth Military Medical University. The author has contributed to research in topics: Breast cancer & Metastasis. The author has an hindex of 8, co-authored 17 publications receiving 250 citations.
Papers
More filters
Journal ArticleDOI
Three dysregulated microRNAs in serum as novel biomarkers for gastric cancer screening
Hui Wang,Lei Wang,Zheng Wu,Rong Sun,Haifeng Jin,Jifeng Ma,Lili Liu,Rui Ling,Jun Yi,Ling Wang,Jie-fang Bian,Jianghao Chen,Nanlin Li,Shifang Yuan,Jun Yun +14 more
TL;DR: Significantly elevated expression of the three miRNAs was also observed in advanced GC patients, which suggested their availability in cancer staging, and confirmed the diagnostic value of serum miR-223, mi-16, and mi-100 in GC.
Journal ArticleDOI
Subanesthetic isoflurane reduces zymosan-induced inflammation in murine Kupffer cells by inhibiting ROS-activated p38 MAPK/NF-κB signaling.
Hui Wang,Lei Wang,Nanlin Li,Jun-tang Li,Feng Yu,Ya-Li Zhao,Ling Wang,Jun Yi,Jie-fang Bian,Jianghao Chen,Shifang Yuan,Ting Wang,Yonggang Lv,Ning-Ning Liu,Xiao-Shan Zhu,Rui Ling,Jun Yun +16 more
TL;DR: Results suggest that volatile anesthetic isoflurane ameliorates ZY-induced inflammatory responses in murine KCs by inhibiting the interconnected ROS/p38 MAPK/NF-κB signaling pathways.
Journal ArticleDOI
Prognostic significance of USP22 as an oncogene in papillary thyroid carcinoma
Hui Wang,Yongping Li,Jianghao Chen,Shifang Yuan,Ling Wang,Juliang Zhang,Qing Yao,Nanlin Li,Jie-fang Bian,Jing Fan,Jun Yi,Rui Ling +11 more
TL;DR: USP22 expression was an independent prognostic marker of overall patient survival in a multivariate analysis and suggest that USP22 is an independent predictor of poor prognosis of PTC patients.
Journal ArticleDOI
Enforced expression of hsa-miR-125a-3p in breast cancer cells potentiates docetaxel sensitivity via modulation of BRCA1 signaling
TL;DR: Findings suggest that hsa-miR-125a-3p may function as a tumor suppressor by regulating the BRCA1 signaling, and reintroduction of hsa/miR/3p analogs could be a potential adjunct therapy for advanced/chemoresistant BCa.
Journal ArticleDOI
Steroidal saponin of Trillium tschonoskii. Reverses multidrug resistance of hepatocellular carcinoma
Hui Wang,Zhenbo Zhai,Nanlin Li,Haifeng Jin,Jianghao Chen,Shifang Yuan,Ling Wang,Juliang Zhang,Yongping Li,Jun Yun,Jing Fan,Jun Yi,Rui Ling +12 more
TL;DR: It is found TTS could reverse the MDR in HCC cells and significantly enhance chemosensitization and induced R-HepG2 sensitization to doxorubicin and therefore reduced tumour formation in vivo.